A Phase 2 Study Evaluating the Co-Administration of Bremelanotide With Tirzepatide for the Treatment of Obesity
Study sponsor: Palatin Technologies, Inc · PTN
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2025-02-05Actual
Enrollment · participants108Estimated
Source updated2025-03-06Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.